Graham Ogg Selected Research

Interleukin-17 (Interleukin 17)

10/2019

Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Graham Ogg Research Topics

Disease

9	COVID-19 01/2023 - 01/2020
9	Infections 01/2023 - 01/2011
8	Atopic Dermatitis (Atopic Eczema) 03/2023 - 02/2016
6	Neoplasms (Cancer) 04/2024 - 04/2002
6	Inflammation (Inflammations) 01/2022 - 01/2012
4	Hypersensitivity (Allergy) 01/2022 - 01/2016
4	Asthma (Bronchial Asthma) 07/2021 - 05/2015
4	Skin Diseases (Skin Disease) 01/2021 - 02/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 10/2016
2	Chronic Urticaria 01/2022 - 01/2021
2	Human Influenza (Influenza) 01/2021 - 01/2014
2	Communicable Diseases (Infectious Diseases) 10/2009 - 01/2007
2	Lymphoma (Lymphomas) 01/2007 - 04/2002
1	Eczema 03/2023
1	Allergic Contact Dermatitis 03/2023
1	Glioblastoma (Glioblastoma Multiforme) 12/2022
1	Testicular Neoplasms (Testicular Cancer) 12/2022
1	Disease Progression 01/2022
1	Critical Illness (Critically Ill) 01/2021
1	Urticaria (Hives) 01/2021
1	Pruritus (Itching) 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Dermatitis 10/2019
1	Eosinophilia 01/2018
1	Venom Hypersensitivity 01/2016
1	Herpes Zoster 02/2013
1	Chickenpox 02/2013
1	Multiple Sclerosis 09/2011
1	Autoimmune Diseases (Autoimmune Disease) 09/2011
1	Immune Reconstitution Inflammatory Syndrome 09/2011
1	Encephalitis (Encephalitis, Rasmussen) 09/2011
1	Shock 01/2011
1	Dengue (Dengue Fever) 01/2011
1	Severe Dengue 01/2011

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 01/2023 - 06/2004
10	Peptides (Polypeptides)IBA 01/2022 - 04/2002
8	LipidsIBA 01/2023 - 10/2016
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
4	CytokinesIBA 07/2021 - 01/2018
4	VaccinesIBA 06/2020 - 01/2007
3	dupilumabIBA 03/2023 - 01/2021
3	Filaggrin ProteinsIBA 01/2022 - 02/2016
3	Phospholipases (Phospholipase)IBA 01/2022 - 02/2015
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 01/2022
2	Interleukin-22 (IL-22)IBA 01/2022 - 10/2019
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
2	Omalizumab (Xolair)FDA Link 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2020
2	InterferonsIBA 11/2020 - 09/2011
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2020 - 01/2011
2	ChemokinesIBA 01/2020 - 01/2018
2	Monoclonal AntibodiesIBA 10/2019 - 09/2011
2	Interleukin-4 (Interleukin 4)IBA 10/2019 - 09/2011
1	Methotrexate (Mexate)FDA LinkGeneric 03/2023
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2023
1	SARS-CoV-2 spike proteinIBA 01/2023
1	ChAdOx1 nCoV-19IBA 01/2023
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2023
1	Decitabine FDA Link 12/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	LigandsIBA 01/2022
1	NickelIBA 01/2022
1	acyloxyacyl hydrolaseIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 07/2021
1	Viral AntigensIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	Immunodominant EpitopesIBA 06/2020
1	Chemokine CCL5IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Immunoglobulin G (IgG)IBA 10/2019
1	Interleukin-33IBA 10/2019
1	Interleukin-13IBA 10/2019
1	InflammasomesIBA 10/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	Interleukin-9 (Interleukin 9)IBA 10/2019
1	Interleukin-17 (Interleukin 17)IBA 10/2019
1	Interleukin-5 (Interleukin 5)IBA 10/2019
1	Thymic Stromal LymphopoietinIBA 12/2017
1	HaptensIBA 02/2016
1	VenomsIBA 01/2016
1	Wasp Venoms (Venom, Wasp)IBA 01/2016
1	Prostaglandin D2IBA 05/2015
1	Leukotriene E4IBA 05/2015
1	EmulsionsIBA 01/2014
1	HLA-A*02:01 antigenIBA 01/2014
1	Prostaglandins DIBA 01/2012
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2012
1	Natalizumab (Tysabri)FDA Link 09/2011
1	AntibodiesIBA 09/2011
1	EpitopesIBA 01/2011
1	HLA-A31 antigenIBA 01/2011
1	OvalbuminIBA 01/2007

Therapy/Procedure

5	Therapeutics 03/2023 - 04/2002
4	Immunotherapy 04/2024 - 10/2009
1	Phototherapy (Light Therapy) 03/2023
1	Length of Stay 07/2021